Kazia Therapeutics (KZIA) Depreciation & Amortization - Total (2011)

Kazia Therapeutics (KZIA) posted Depreciation & Amortization - Total of $125370.2 for Q4 2011.

Kazia Therapeutics (KZIA) Depreciation & Amortization - Total (2011) Analysis & Trends

Kazia Therapeutics' Depreciation & Amortization - Total history runs 1 years deep, the most recent figure standing at $125370.2 for Q4 2011.

Quarterly Depreciation & Amortization - Total changed N/A year-over-year to $125370.2 in Q4 2011, while the trailing twelve-month figure through Dec 2012 was $125370.2 (changed 0.0% YoY) and the FY2011 annual result came in at $128030.9, changed N/A from the prior year.
Depreciation & Amortization - Total was $125370.2 for Q4 2011 at Kazia Therapeutics.
Across five years, Depreciation & Amortization - Total topped out at $125370.2 in Q4 2011 and bottomed at $125370.2 in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Dep. & Amort. (Tot) (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	-
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Kazia Therapeutics	19.25 Bn	19.25 Bn	-	-

Download Data

Date	Value
Dec 31, 2011	125,370.23